Investing.com - Taiwan Liposome ADR reported on Friday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Taiwan Liposome ADR announced earnings per share of $-0.1708 on revenue of $1.34M. Analysts polled by Investing.com anticipated EPS of $-0.1633 on revenue of $483.33K.
Taiwan Liposome ADR shares are up 23.48% from the beginning of the year, still down 56.76% from its 52 week high of $12.65 set on July 15, 2020. They are outperforming the Nasdaq which is up 4.2% from the start of the year.
Taiwan Liposome ADR follows other major sector earnings this month
Taiwan Liposome ADR's report follows an earnings beat by Industrial Commercial Bank of China on April 29, who reported EPS of $0.7417 on revenue of $33.09B, compared to forecasts EPS of $0.6343 on revenue of $34.72B.
L’Oreal ADR had matched expectations on April 15 with first quarter EPS of $1.03 on revenue of $9.12B, compared to forecast for EPS of $1.03 on revenue of $9.23B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar